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Normal heart development is orchestrated by a set of highly conserved transcription factors that includes GATA4, Nkx2-5, and Tbx5.
Heterozygous mutation of each of these genes causes congenital heart disease in humans. In mouse models, haploinsufficiency for Nkx2-5 or
Tbx5 resulted in an increased incidence of structural heart disease, confirming that normal heart development is sensitive to small changes in
expression levels of Nkx2-5 and Tbx5. However, mice haploinsufficient for GATA4 have not been reported to have cardiac abnormalities.
We generated two new GATA4 alleles, GATA4H and GATA4flox. GATA4flox/flox embryos expressed 50% less GATA4 protein in the heart and
survived normally. In contrast, GATA4H/H embryos expressed 70% less GATA4 protein in the heart and died between days 13.5 and 16.5 of
gestation. These embryos had common atrioventricular canal (CAVC), double outlet right ventricle (DORV), hypoplastic ventricular
myocardium, and normal coronary vasculature. Myocardial hypoplasia was associated with diminished cardiomyocyte proliferation.
Hemodynamic measurements demonstrated that these embryos had normal systolic function, severe diastolic dysfunction, and
atrioventricular regurgitation. Surprisingly, expression levels of the putative GATA4 target genes ANF, BNP, MEF2C, Nkx2-5, cyclin D2,
and BMP4 were unchanged in mutant hearts, suggesting that GATA4 is not a dose-limiting regulator of the expression of these genes during
later stages of embryonic cardiac development. These data demonstrate that multiple aspects of embryonic cardiac morphogenesis and
function are exquisitely sensitive to small changes in GATA4 expression levels.
D 2004 Elsevier Inc. All rights reserved.
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Congenital heart disease is the most common major
congenital anomaly, with an incidence of 1 in 200 live births
(Hoffman, 1995). Growth and maturation of the fetal heart is
regulated by a set of highly conserved transcription factors
that includes GATA4, Nkx2-5, and Tbx5 (Srivastava and
Olson, 2000). Mutation of one copy of these genes is
associated with cardiac malformations in humans, presum-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: wpu@enders.tch.harvard.edu (W.T. Pu).ably as a result of haploinsufficiency (Basson et al., 1997;
Garg et al., 2003; Pehlivan et al., 1999; Schott et al., 1998).
The sensitivity of heart development to dosage of Nkx2-5 or
Tbx5 was recapitulated in mouse models in which targeted
ablation of one copy of these genes resulted in an increased
frequency of cardiac malformations (Biben et al., 2000;
Bruneau et al., 2001). However, the pathogenesis of heart
malformations in humans with missense or nonsense
mutations in GATA4 is less well understood since hap-
loinsufficiency for GATA4 in mice was not reported to be
associated with cardiac malformations (Kuo et al., 1997;
Molkentin et al., 1997).
The zinc finger transcription factor GATA4 and its
binding partner FOG2 are essential components of the fetal275 (2004) 235–244
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resulted in abnormal ventral folding of the embryo, failure
to form a single ventral heart tube, and lethality by
embryonic day (E) 10.5 (Kuo et al., 1997; Molkentin et
al., 1997). GATA4 is also essential for later cardiac
morphogenesis since embryos homozygous for a GATA4
point mutation (GATA4Ki) that abolished interaction with
FOG2 died just after E12.5. These embryos had cardiac
malformations that included hypoplasia of the compact
myocardium, common atrioventricular canal (CAVC), and
double outlet right ventricle (DORV) (Crispino et al., 2001).
Similarly, FOG2 null embryos had hypoplasia of the
compact myocardium, CAVC, and normally related great
arteries (Tevosian et al., 2000). Strikingly, both GATA4Ki/Ki
and FOG2 null hearts were reported to have an absence of
the coronary vasculature (Crispino et al., 2001; Tevosian et
al., 2000).
Using gene targeting, we generated a new hypomorphic
allele of GATA4, GATA4H, which expressed reduced
amounts of GATA4 protein. In this report, we characterize
mouse embryos homozygous for this hypomorphic allele
and demonstrate that the level of cardiac GATA4
expression is an important regulator of cardiomyocyte
proliferation, cardiac morphogenesis, and embryo survival.Fig. 1. GATA4 alleles produced by gene targeting. (a) Modification of
targeted locus by expression of Cre and Flp recombinases. Open box, 5V
UTR; black box, coding region; solid line, regions of homology
between genomic locus and targeting vector; dashed line, flanking
genomic DNA. Triangles, loxP and Frt sequences; H3, HindIII; R,
EcoRI; Xb, XbaI; X, XhoI; TK, thymidine kinase; Kan-Neo, Kan
resistance and pgk-Neo cassettes. Blue lines indicated expected length of
diagnostic fragments used in Southern blotting. (b) Proper homologous
recombination verified by Southern blotting. ES cell genomic DNA was
digested with HindIII (3V probe) or XbaI and XhoI (5V probe). Arrows
indicate bands with sizes expected following proper targeting. (c) Proper
recombination of Frt and loxP sites after transient expression of Flp
(WT/flox lane) or Cre (WT/D lane) recombinase in a properly targeted
ES cell clone. ES cell genomic DNA was digested with EcoRI and
hybridized to the 5Vprobe.Materials and methods
Gene targeting
A bacterial artificial chromosome containing GATA4
genomic DNA was isolated from a 129/SvJ BAC library
(Genome Systems). A targeting vector was constructed
using the following fragments (Fig. 1a): (1) a thymidine
kinase gene; (2) a 1268-bp NsiI–NheI fragment containing
GATA4 genomic DNA including the 5Vend of exon 2; (3)
an oligonucleotide containing a loxP site and an XhoI site;
(4) a 1302-bp NheI–EcoRV fragment containing GATA4
genomic DNA including the 3Vend of exon 2; (5) an Frt-
Kan-Neo-Frt-loxP cassette; and (6) a 2762-bp EcoRV–
EcoRI fragment containing GATA4 genomic DNA from
the second intron. The targeting vector was used to
modify the GATA4 locus of embryonic stem cells by
homologous recombination. Neomycin-resistant clones
were tested for correct gene targeting by Southern blotting
using 5Vand 3Vprobes (Fig. 1b) and by PCR using primer
pairs spanning the targeting vector and flanking genomic
DNA (not shown). To confirm proper activity of loxP and
Frt sites, colonies derived from transient transfection of a
targeted ES cell clone with a plasmid expressing either
Cre or Flp recombinase were tested for loss of Neo
resistance. Seven out of 48 colonies were sensitive to
G418 after transient Flp expression. Twenty-three out of
48 colonies were sensitive to G418 after transient Cre
expression. No colonies were sensitive to G418 after
transfection with a control plasmid. Southern blotting ofNeo-sensitive colonies confirmed expected DNA recombi-
nation (Fig. 1c).
Mice
Chimeric mice were generated from one properly
targeted clone by blastocyst injection. Germline trans-
mission was achieved by mating to C57BL6 mice. Mice
used in this study were on a mixed 129/C57BL6 genetic
background, backcrossed to C57BL6 2–5 generations.
DNA extracted from tail biopsies and yolk sacs were
genotyped by PCR (primers and protocols available on
request). Susan Dymecki provided hactBDFLPe trans-
genic mice (Rodriguez et al., 2000). EIIaCre mice were
obtained from Fred Alt (Williams-Simons and Westphal,
1999). Timed matings were performed by examining
females for vaginal plugs, with noon of the day of the
Fig. 2. Survival of offspring homozygous for modified GATA4 alleles. The
graph displays the frequency of offspring with the indicated genotype from
heterozygous intercrosses. The number of offspring genotyped for each
point is indicated. P20, postnatal day 20.
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was administered by intraperitoneal injection 2 h before
sacrifice.
Embryo physiology
Preparation and hemodynamic evaluation of mouse
embryos were performed as described previously (Ishiwata
et al., 2003). In brief, each embryo was exposed in a bath
containing Hank’s balanced salt solution at 378C. The
ventricular systolic and diastolic areas were obtained by
tracing the epicardial border on frontal images recorded with
a color CCD camera mounted on a stereoscopic microscope.
Blood velocities across ventricular inflow were measured
with a 20-MHz pulsed Doppler velocimeter. Blood pressure
in ventricles was measured with a servo-null micropressure
system attached to a 10-Am glass pipette that was inserted
directly into the ventricle.
Histology
Embryos were fixed overnight in 4% paraformaldehyde,
dehydrated, and embedded in paraffin. Five- to 10-Am
sections were cut and stained with hematoxylin and eosin.
Three-dimensional reconstruction was performed using
SURFdriver software. BrdU staining was performed on
paraffin sections using BrdU antibody (Sigma), the M.O.M.
staining kit (Vector), and tyramide-Cy3 (Perkin-Elmer) as
the HRP substrate. Nuclei were counterstained with
TOPRO3 (Molecular Probes), and cardiomyocytes were
stained with a rabbit desmin antibody (BioMeda) and
donkey anti-rabbit Alex488 (Molecular Probes). TUNEL
staining was performed on paraffin sections using the TMR
Red in situ Death Detection Kit (Roche). Fluorescent images
were acquired with a confocal microscope (Bio-Rad).
Gene expression
In situ hybridization was performed as described
previously (Tanaka et al., 1999), using 35S-labeled probes
for GATA4 (Molkentin et al., 1997), ANF (Zeller et al.,
1987), and N-myc (Tanaka et al., 1999). Quantitative real-
time RT-PCR (qRT-PCR) was performed on an ABI7700
using Taqman probes for GATA4, GATA6, MEF2C, Nkx2-5,
BMP4, cyclins D1-D3, and HOP and normalized to 18 S
rRNA. ANF, BNP, and GAPDH were measured by qRT-
PCR using Sybr Green detection. Primer and probe
sequences are available at http://www.cardiogenomics.org.
Total RNA from E12.5 or E13.5 hearts was isolated using
the RNeasy kit (Qiagen) with on-column DNase digestion.
Each sample consisted of two to three pooled hearts,
assayed in duplicate. Three samples were analyzed per
group. Western blots were performed using 50 Ag of total
protein. GATA4 was detected with rabbit polyclonal anti-
body (Santa Cruz) and normalized to GAPDH (Research
Diagnostics).Results
Generation of gene-targeted mice
To circumvent the extracardiac early embryonic lethality
seen in GATA4 null embryos, we generated a floxed
GATA4 allele (Fig. 1a). A targeting construct was used to
modify the GATA4 locus in embryonic stem cells by
homologous recombination, yielding the allele GATA4H.
The targeted allele contains a loxP site in the 5Vuntranslated
region of exon 2, 468 bp upstream of the initiation codon,
and a neomycin resistance cassette in the second intron. The
loxP site was oriented so that no ATG sequence was
introduced in the 5V untranslated region. Correct targeting
was verified by Southern blotting (Fig. 1b) and PCR (not
shown). Properly targeted ES cells were used to generate
gene-targeted mice. GATA4wt/H mice were mated to EIIaCre
mice (Williams-Simons and Westphal, 1999) to delete exon
2 in the germline, creating the allele GATA4D (Fig. 1a),
which is similar in structure to a previously described null
allele (Kuo et al., 1997). To delete the resistance cassette,
GATA4wt/H mice were mated to hactBDFLPe transgenic
mice (Rodriguez et al., 2000), giving the allele GATA4flox
(Fig. 1a).
Detailed analysis of each of these alleles indicated that
GATA4D is a null allele, while GATA4H is a severe and
GATA4flox a mild hypomorphic allele. Analysis of embryos
from timed matings between GATA4wt/D mice showed that
GATA4D/D embryos did not survive beyond E10.5 (Fig. 2).
Mutant embryos displayed severe abnormalities of ventral
folding (data not shown), consistent with previously
described GATA4 null alleles (Kuo et al., 1997; Molkentin
et al., 1997). Intercrosses between GATA4wt/H mice did not
produce any live GATA4H/H offspring (0/167), and analysis
of litters from timed matings showed that GATA4H/H
embryos died between E13.5–E16.5 (Fig. 2). These find-
ings demonstrated that GATA4H is a hypomorphic allele.
Removal of the neomycin resistance cassette resulted in
GATA4flox, which is compatible with normal survival
since intercrosses between GATA4wt/flox mice produced
GATA4flox/flox offspring at the expected Mendelian fre-
quency (32/132, 24%; Fig. 2).
Table 1
Cardiac morphology of GATA4H/H
+/+ GATA4H/H
n 18 18
Normal 17 (94) 0
Atria
RA dilatation 0 7 (39)
AV Junction
CAVC 0 11a (61)
Partial AVC 0 1b (6)
Ventricles
Spongy septum 0 10 (56)
Hypoplasia 0 18 (100)
Inlet VSD 0 12 (67)
Membranous VSD 1 (6) 2c (11)
Musc VSD 0 2 (11)
Outflow
DORV 0 16 (89)
a Two unbalanced canal, LV dominant.
b
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To determine the reason that the GATA4H allele fails to
support normal survival, we compared expression of
GATA4 mRNA and protein in hearts from E13.5
GATA4H/H embryos and wild-type littermates. In situ
hybridization revealed that GATA4 transcripts were nor-
mally distributed in GATA4H/H hearts (Fig. 3a). In both
wild-type and mutant embryos, GATA4 is expressed at
highest levels in the endocardium of the atrioventricular
canal and in the atrioventricular endocardial cushions (Figs.
3a and b). Robust GATA4 expression was also present in
wild-type and mutant myocardium (Figs. 3a and b). In
E10.5 embryos, GATA4 was expressed similarly in the
proepicardial derivatives of both wild-type and mutant
hearts (data not shown). By E14, the epicardium is
relatively thin and expression in this structure is difficultFig. 3. GATA4 mRNA and protein expression in GATA4 mutant embryos.
(a) Dark-field images demonstrating GATA4 expression (pink) in
GATA4H/H and wild-type hearts, detected by in situ hybridization using
a full-length GATA4 probe. White box indicates area magnified in panel
b. (b) Higher magnification of the right atrioventricular groove. To
facilitate anatomical localization of the GATA4 in situ hybridization
signal, it is displayed as blue pseudocolor overlaid on the bright-field
eosin-stained image. GATA4 is expressed in endocardium (En), myocar-
dium (Myo), and epicardium (Ep). RA, right atrium; RV, right ventricle.
(c) GATA4 mRNA from E13.5 GATA4H/H and GATA4+/+ hearts. GATA4
transcript was analyzed by Northern blotting using a full-length GATA4
probe, and by quantitative RT-PCR, normalized to 18 S rRNA. *P b 0.05.
(d) GATA4 protein in mutant and wild-type E13.5 hearts. GATA4 protein
from H/H, flox/flox, and wild-type E13.5 hearts was analyzed by Western
blotting. Each sample was pooled from two hearts. (d) Quantitative
analysis of GATA4 protein expression, normalized to GAPDH. Each
value represents the average of three samples, each pooled from two
hearts. *P b 0.05. W, wild-type; F, GATA4flox/flox; H, GATA4H/H.
No primum ASD.
c Membranous VSDs with extension into the inlet septum.to resolve from myocardial expression by radioactive in
situ hybridization. In the atrioventricular grooves, where
epicardial cells tend to be heaped up, epicardial GATA4
expression was detected in both wild-type and mutant
embryos (Fig. 3b). By Northern blotting, GATA4 tran-
scripts from mutant hearts were normal in size and 30%
reduced in abundance (Fig. 3c, left panel). qRT-PCR
showed that GATA4 mRNA levels were normal in
GATA4flox/flox hearts but 50% reduced in GATA4H/H hearts
(Fig. 3c, right panel). Sequencing of GATA4 cDNA
fragments amplified from GATA4H/H hearts demonstrated
that the coding region was identical to wild type, and no
aberrant splice variants could be detected by PCR using
primers spanning each intron–exon junction.
By Western blotting, GATA4 protein expressed from the
GATA4H allele was normal in size (Fig. 3d). The amount of
GATA4 protein, normalized to GAPDH, was reduced by 70%
in GATA4H/H hearts (Fig. 3d). In GATA4flox/flox hearts,
GATA4 protein was present at an intermediate level (50%
reduction compared to wild-type controls; Fig. 2c). This
small difference in GATA4 protein levels was associated with
a profound difference in embryonic survival (Fig. 2).
Abnormal cardiac morphogenesis in GATA4H/H embryos
By E13.5, GATA4H/H embryos appeared edematous and
the right atrium was dilated, displacing the heart to the left
(Figs. 4a and b). Mutant hearts had common atrioventricular
canal (CAVC), usually well balanced but occasionally with a
relatively small right ventricle (Fig. 4b; Table 1). The
interventricular septum had a characteristic spongiform
appearance (Fig. 4b; Table 1), and the compact and trabecular
myocardium were markedly hypoplastic (Figs. 4b and 5a and
b). The aorta was connected with the right ventricle, resulting
in a double outlet right ventricle (Figs. 4b and c). A subaortic
Fig. 4. Morphology of GATA4H/H embryos. (a) Mutant embryos had body wall edema (green arrowheads) and dilated right atria (outlined in black),
displacing the heart to the left. Scale bar = 1 mm. (b) Serial hematoxylin-and-eosin-stained transverse sections of hearts from wild-type and mutant E14.5
littermate embryos. The GATA4H/H heart demonstrated CAVC (*, left panel), hypoplasia of the compact and trabecular myocardium, and dilated right
atrium. The aortic (middle panel) and the pulmonary valves (right panel) both connected to the right ventricle in the mutant embryo. Scale bar = 0.5 mm.
(c) Three-dimensional reconstruction of a GATA4H/H heart showing DORV. Both semilunar valves were related exclusively to the right ventricle, with the
aortic valve inferior, posterior, and to the right of the pulmonary valve. (d) Dorsal surface of wild-type and GATA4H/H littermate ventricles at E13.5.
Coronary vasculature was identified by whole mount PECAM staining. No difference in staining was seen between wild-type and mutant hearts. (e) Blood-
filled left main coronary artery (arrows) in a GATA4H/H heart. (f) Blood-filled small epicardial coronary arteries (arrows) in the interventricular groove of a
GATA4H/H heart. (g) Intramyocardial coronary arteries (arrowheads) in a GATA4H/H heart. Green, PECAM; red, desmin. Dashed white line indicates inner
margin of the compact myocardium; d–g, scale bar = 0.05 mm. RA, right atrium; RV, right ventricle; LA, left atrium; LV, left ventricle; AoV, aortic valve;
PV, pulmonary valve; Ao, aorta.
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inferior, posterior, and to the right of the pulmonary valve
(Fig. 4c).
A previously described GATA4 hypomorphic allele,
GATA4Ki, expressed normal amounts of a mutant GATA4
protein that failed to interact with FOG2 due to a V217G
mutation. GATA4Ki/Ki embryos died around E12.5, and like
GATA4H/H hearts, GATA4Ki/Ki hearts had CAVC, DORV, and
ventricular hypoplasia. GATA4Ki/Ki hearts had a striking
paucity of coronary vasculature (Crispino et al., 2001). In
contrast, we found that GATA4H/H hearts had normal, blood-
filled epicardial coronary vessels (Figs. 4d–f). PECAM
staining demonstrated the presence of intramyocardial
coronary vessels (Fig. 4g).
Hypoplasia of the compact and trabecular myocardium in
GATA4H/H embryos (Figs. 5a and b) may have been due to
increased cardiomyocyte apoptosis or decreased cardiomyo-
cyte proliferation. TUNEL staining of E12.5 and E13.5 heartsdid not reveal a difference in the rate of apoptosis between
mutant embryos and wild-type littermate controls (data not
shown). However, cardiomyocyte proliferation, as assessed
by BrdU labeling, was significantly decreased in GATA4H/H
compact myocardium compared to wild-type littermate
controls at E12.5 (Figs. 5c and d). While mutant hearts also
had marked hypoplasia of the trabecular myocardium, we did
not detect a difference in the frequency of BrdU-positive cells
in the trabecular myocardium at E12.5 (Fig. 5d).
Trabecular myocardium and compact myocardium have
distinct gene expression programs. In normal hearts, at
E13.5 ANF was expressed at high levels in trabecular but
not compact myocardium (Fig. 5e), while N-myc was
expressed at higher levels in compact compared to
trabecular myocardium (Fig. 5f). The outer margin of
ANF expression and the inner margin of N-myc expression
(dashed line, Figs. 5e–f) coincided with the morphological
junction between compact and trabecular myocardium (solid
Table 2
Hemodynamic measurements in E13.5 embryos
WT H/H p
Video microscopy
n 13 12
HR 200 F 3 225 F 10 b0.05
LVEDA (mm2) 0.78 F 0.01 0.79 F 0.01
LVESA (mm2) 0.52 F 0.02 (13) 0.52 F 0.01
LVAEF (%) 34.8 F 1.3 34.8 F 0.9
RVEDA (mm2) 1.27 F 0.03 1.27 F 0.03
RVESA (mm2) 0.83 F 0.02 0.81 F 0.02
RVAEF (%) 33.9 F 0.67 36.4 F 1.33
Doppler velocimetry
n 11 10
E (mm/s) 25 F 1 52 F 3 b0.001
A (mm/s) 97 F 2 103 F 5
E/A 0.26 F 0.00 0.50 F 0.03 b0.001
Intraventricular pressure
n 7 4
Peak (mm Hg) 9.00 F 0.40 6.75 F 0.16 b0.005
EDP (mm Hg) 0.79 F 0.03 1.05 F 0.06 b0.005
A kick (mm Hg) 2.05 F 0.04 1.90 F 0.12
Sucking (mm Hg) 0.60 F 0.03 0.15 F 0.09 b0.001
+dP/dt (mm Hg/s) 217 F 8 196 F 9
dP/dt (mm Hg/s) 185 F 3 155 F 5 b0.001
LV, left ventricle; RV, right ventricle; EDA, end diastolic area; ESA, end
systolic area; AEF, area ejection fraction; EDP, end diastolic pressure.
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be expressed at high levels in trabecular myocardium, but
the outer margin of ANF expression (dashed line) occurred
in a region of myocardium with a trabecular appearance
(Fig. 5e). Similarly, the inner margin of N-myc expression
(dashed line) occurred in a region of myocardium with a
trabecular appearance (Fig. 5f). These data indicate that in
mutant embryos there was a region of dysplastic myocar-
dium that expressed the genetic program of compact
myocardium but had trabecular morphology.
Impaired diastolic function Of GATA4H/H hearts
To determine the effect of the hypomorphic GATA4
mutation on embryo cardiac function, we used video
imaging, Doppler velocimetry, and intracardiac pressure
measurements to evaluate the hemodynamics of E13.5
embryos (Fig. 6; Table 2). We found that ventricular size
was no different between mutant and wild-type embryos
(Table 2). Systolic function, as assessed by area ejection
fraction and +dP/dt, was also normal in GATA4H/H
embryos, although peak ventricular pressure was reduced
in mutant embryos (Table 2), perhaps as a result of
atrioventricular regurgitation (see below). Diastolic func-
tion, as assessed by the ratio of early (bEQ) to late (bAQ)
ventricular inflow velocities, dP/dt, ventricular end-dia-
stolic pressure, and ventricular sucking pressure, was
severely impaired in GATA4H/H embryos (Table 2). We
also qualitatively assessed competency of the atrioventric-
ular (AV) valves by measuring blood flow in the inferiorvena cava. We detected systolic retrograde flow in mutant
embryos, indicating that the hypoplastic AV valves of
mutant hearts were regurgitant (Fig. 6c).
Gene expression in GATA4H/H hearts
To determine if chamber- and subregion-specific genetic
programs were normally specified in GATA4H/H embryos,
we used in situ hybridization to detect subregion-restricted
transcripts. MLC2a and MLC2v, which are restricted to
atrial and ventricular myocardium, respectively, were
normally expressed in GATA4H/H hearts (data not shown).
Tbx5 retained its normal preferential expression in the atria
and the left ventricle (data not shown).
Based on promoter assays in transfected cultured cells and
in some cases promoter studies in transgenic animals,
GATA4 has been implicated in the regulation of a number
of genes expressed in the heart. To determine if variation of
GATA4 expression levels within a physiologically relevant
range influences expression of putative GATA4 target genes,
we measured the expression of selected genes by quantitative
RT-PCR (Fig. 7). GATA6 expression was not altered in
GATA4H/H embryos, in contrast to the compensatory up-
regulation of GATA6 reported in GATA4 null embryos
(Molkentin et al., 1997). Although in vivo promoter analysis
indicated that GATA sites were essential for normal activity
of the Nkx2-5 and MEF2C enhancers (Lien et al., 1999;
Searcy et al., 1998; B. Black, personal communication),
Nkx2-5 levels were up-regulated twofold in GATA4H/H
hearts while MEF2C expression was unchanged (Fig. 7).
Likewise, ANF and BNP expression levels were not altered
in GATA4H/H hearts (Fig. 7) despite the extensive literature
suggesting an important role for GATA4 in the activation of
these promoters. Because of the reduced replication rate of
GATA4H/H myocytes, we also measured expression of cyclin
D1–3 and the homeodomain only protein (HOP), which
regulates myocardial growth and is a direct target of the
GATA4 interacting transcription factor Nkx2-5 (Chen et al.,
2002; Shin et al., 2002). Cyclin D2, cyclin D3, and HOP
expression were not significantly changed in E12.5 mutant
hearts, while cyclin D1 expression was slightly up-regulated
in mutant hearts (Fig. 7). Finally, we examined the
expression of BMP4 because BMP4 has been reported to
be a target of GATA4 and atrioventricular canal formation is
sensitive to BMP4 dosage. We did not detect a difference in
BMP4 expression by in situ hybridization in E10.5 hearts
(data not shown) or by RT-PCR in E13.5 hearts (Fig. 7).Discussion
GATA4 regulation of cardiac morophogenesis
We have generated and characterized a hypomorphic
allele of GATA4, GATA4H. GATA4H/H embryos expressed
70% lower levels of GATA4 protein (Fig. 3). These mutant
Fig. 5. Hypoplasia and dysplasia of ventricular myocardium in GATA4H/H hearts. (a) Left ventricle of mutant and wild-type hearts at the level of the major
papillary muscles. (b) Quantitative analysis of compact and trabecular areas, normalized to ventricular circumference. The compact and trabecular areas of
mutant RV and mutant LV were significantly reduced compared to littermate controls (n = 5; *P b 0.001). (c) BrdU staining (red) of GATA4H/H and wild-type
left ventricle at E12.5. Nuclei were detected by TOPRO-3 staining (blue). Lower panels are the same images as the upper panels, with cardiomyocytes
identified by desmin staining (green). Arrows indicate BrdU-positive cardiomyocyte nuclei. (d) Quantitative analysis of cell replication in E12.5 mutant and
wild-type hearts. BrdU labeling index was calculated as the ratio of BrdU-positive cardiomyocyte nuclei to total cardiomyocyte nuclei. More than 200 nuclei
were counted for each measurement per embryo. Mutant embryos were compared to their respective wild-type littermates. Each group contained three embryos.
*P b 0.05. NS, no significant difference. (e) Abnormal regional expression of ANF in mutant hearts. In control hearts, ANF (blue in situ hybridization signal)
was expressed in trabecular myocardium all the way to the junction with compact myocardium (solid line). In mutant hearts, the ANF expression domain
(dashed line) did not extend to the morphological compact myocardium. The bracket indicates a region with trabecular appearance but lacking ANF expression.
(f) Abnormal regional expression of N-myc in mutant hearts. In control hearts, N-myc was most highly expressed in compact myocardium (blue in situ
hybridization signal). In mutant hearts, the domain of higher level N-myc expression (dashed line) extended beyond the morphological compact myocardium
(solid line).
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4). GATA4H/H embryos died between E13.5 and E16.5, with
right atrial dilatation and peripheral edema suggestive of
congestive heart failure. In comparison, GATA4flox/flox
embryos, which had a 50% reduction of GATA4 protein
(Fig. 3), survived normally (Fig. 2) and had normal
postnatal cardiac function and fertility (WTP and SI,
unpublished data). These data indicate that small changes
in the level of GATA4 protein expression can dramatically
influence cardiac morphogenesis and embryonic survival.
Consistent with this conclusion is the association of
mutations of GATA4 with cardiac septation defects in
humans (Garg et al., 2003). The extent to which the
GATA4H allele reduced GATA4 expression is within the
range of GATA4 down-regulation that has been seen with
experimental retinoic acid deficiency (Kostetskii et al.,
1999) and with perturbation of embryonic calcium homeo-
stasis (Porter et al., 2003), suggesting that altered GATA4
activity may contribute to congenital heart disease due to
both genetic and environmental factors.The morphology of GATA4Ki/Ki hearts was similar to
GATA4H/H hearts, with both having CAVC, DORV, and
marked hypoplasia of the compact myocardium (Crispino et
al., 2001). This similarity indicates that many dosage-
sensitive aspects of GATA4 function in late cardiac
morphogenesis are dependent upon interaction with a
FOG cofactor. Both GATA4Ki/Ki and GATA4H/H hearts
have striking myocardial hypoplasia (Fig. 5). The hypo-
plasia of the compact myocardium in GATA4H/H embryos
was due at least in part to decreased cardiomyocyte
replication at E12.5. Although we did not find a difference
in BrdU labeling index in trabecular myocardium at E12.5
or E13.5, it is possible that earlier time points would have to
be examined since the most rapid rate of growth of
trabecular myocardium precedes E12.5 (Ishiwata et al.,
2003). GATA factors have been implicated in the regulation
of cell proliferation in other systems, potentially through the
regulation of cyclin D2 (Kitta et al., 2003; Suzuki et al.,
2003; Tanaka et al., 2000; Wang et al., 1996). However, we
found that transcription of cyclins D1–3 was unaltered or
Fig. 6. Analysis of embryo hemodynamics. (a) Representative intraventricular pressure tracings from wild-type and mutant embryos. (1) Atrial kick pressure;
(2) EDP; (3) peak systolic pressure; (4) sucking pressure. (b) Representative Doppler recordings of ventricular inflow velocities. E—early diastolic filling; A—
late diastolic filling. (c) Representative Doppler recordings of inferior vena cava flow. There is normally a brief wave of retrograde flow (*) during atrial
contraction (late ventricular diastole). Abnormal systolic retrograde flow, indicated by arrowheads, was detected in all mutant embryos but in no wild-type
embryos.
W.T. Pu et al. / Developmental Biology 275 (2004) 235–244242slightly up-regulated in GATA4H/H embryos (Fig. 7).
Likewise, transcription of HOP, a regulator of myocardial
growth and a target gene of the GATA4 interacting
transcription factor Nkx2-5 (Chen et al., 2002; Shin et al.,
2002), was not changed in GATA4H/H embryos (Fig. 7).
While the overall phenotype of GATA4Ki/Ki and
GATA4H/H hearts was similar, unlike GATA4Ki/Ki hearts
GATA4H/H hearts had blood filled epicardial and intra-
myocardial coronary vessels (Figs. 4d–g). This difference
suggests that coronary vessel formation requires GATA4-Fig. 7. Gene expression in GATA4H/H hearts. Relative expression of
GATA4 target genes, normalized to GAPDH (ANF, BNP) or 18 S, in wild-
type and H/H hearts. Expression was measured by qRT-PCR using total
RNA from E13.5 hearts. *P b 0.05. NS, no significant difference. Three
samples, each composed of hearts from two embryos, were used for each
group and each measurement was made in duplicate.FOG interaction but is not sensitive to a moderate reduction in
GATA4 levels. This implies that GATA4 is necessary for
coronary vessel formation but might not be a dose-limiting
regulator of this process. Although our analysis cannot
completely exclude abnormal perfusion due to abnormal
coronary vessel density or microvascular function, the
equivalent severity of myocardial hypoplasia despite a
marked difference in coronary vascularity in the GATA4Ki/
Ki versus GATA4H/H mutant hearts suggests that the myo-
cardial hypoplasia is not secondary to abnormal perfusion.
We found that the expression domains of ANF and N-
myc, markers that delineate the boundary between compact
and trabecular myocardium, were perturbed in mutant
embryos (Figs. 4e–f) so that mutant embryos had a zone
with the morphology of trabecular myocardium but the
genetic program of compact myocardium (reduced ANF
expression, increased N-myc expression). This phenotype is
reminiscent of ventricular noncompaction, a frequent find-
ing in childhood cardiomyopathy (Nugent et al., 2003) and a
finding associated with a chromosomal microdeletion that
includes GATA4 (Pehlivan et al., 1999). The thin myocar-
dial phenotype of GATA4H/H hearts suggests that GATA4
and its transcriptional targets are candidate genes for human
cardiomyopathies.
GATA4 expression in ventral endoderm has previously
been demonstrated to be sufficient to rescue the defect of
ventral morphogenesis seen in GATA4 null embryos (Narita
et al., 1997). GATA4H/H embryos undergo normal ventral
morphogenesis, suggesting that either the requirement for
GATA4 is less sensitive to expression level in the ventral
endoderm compared to the heart or that the GATA4H allele
W.T. Pu et al. / Developmental Biology 275 (2004) 235–244 243expresses higher amounts of GATA4 in the ventral
endoderm than in the heart.
Hemodynamic abnormalities leading embryonic lethality
Like FOG2D/D embryos (Ishiwata et al., 2003), GATA4H/H
embryos had severely diminished ventricular diastolic
function and normal systolic function (Fig. 6). While it
might seem counterintuitive that the thinner mutant ventricle
was stiffer than wild-type ventricle, diastolic ventricular
filling is an active process. The compact myocardium
expresses relatively higher levels the calcium handling
proteins SERCA2A, phospholambam, and sodium–calcium
exchanger (NCX1) than the trabecular myocardium, and
early ventricular filling is exponentially related to the area of
the compact myocardium (Ishiwata et al., 2003). Our
finding that the thinner walled mutant myocardium had
impaired diastolic function is consistent with these data. In
addition to their effects on myoarchitecture, GATA4 and
FOG2 may also influence diastolic function by altering the
expression of cardiac genes that are important for ventric-
ular relaxation.
Our hemodynamic measurements describe the patho-
physiology leading to death in GATA4H/H embryos. During
systole, a fraction of the ventricular output regurgitated
retrograde due to incompetence of the hypoplastic atrioven-
tricular valves. In the setting of AV regurgitation, normal
rather than supranormal area ejection fraction suggests the
possibility that the mutant embryos also had latent systolic
dysfunction. During diastole, the regurgitant volume did not
reenter the ventricle (EDAwas normal rather than increased
in mutant embryos) because of impaired ventricular
relaxation. As a result, diastolic pressures were elevated,
leading to atrial enlargement and peripheral edema in
mutant embryos (Fig. 4). Moreover, forward cardiac output
was reduced, resulting in death of the embryo. We suspect
that impaired ventricular filling is an important component
of the hemodynamic derangements present in other embryos
with hypoplasia of the compact myocardium.
Regulation of GATA4 downstream targets
GATA4 has been implicated in the regulation of a large
number of cardiac genes (reviewed by Molkentin, 2000),
based largely on reporter assays in cell culture or in
transgenic animals. We tested the hypothesis that GATA4
is a dosage-limiting regulator of transcription of a number of
putative target genes. While ANF, BNP, cyclin D2, and
BMP4 promoters are GATA4 responsive in transient trans-
fection assays, we found that decreased GATA4 protein
levels did not alter expression of these genes in vivo (Figs.
5e and 7), suggesting that changes in GATA4 level within a
physiological range do not alter the expression of these
genes in late cardiogenesis. Consistent with this finding,
ANF was normally expressed in GATA4 null hearts
(Molkentin et al., 1997). However, we cannot exclude morecomplex models in which down-regulation resulting from
decreased GATA4 protein levels is masked by up-regulation
due to other factors, such as heart failure.
The enhancers of the transcription factors Nkx2-5 and
MEF2C contain GATA4 binding sites, and mutation of
these sites altered expression of these genes in transgenic
reporter mice (Lien et al., 1999; Searcy et al., 1998; B.
Black, personal communication). However, MEF2C and
Nkx2.5 transcript levels were unaffected or twofold up-
regulated, respectively, in GATA4H/H hearts, indicating that
the expression of these genes is not sensitive to a moderate
reduction of GATA4 activity late in cardiogenesis. This does
not exclude an important role of GATA4 in inducing or
maintaining the expression of these genes at other stages of
development. The up-regulation of Nkx2-5 in GATA4H/H
hearts was unexpected and may be secondary to the
increased wall stress in mutant hearts. Nkx2-5 was up-
regulated by increased wall stress in adult hearts (Thompson
et al., 1998).Conclusion
GATA4 is an essential, dosage-dependent regulator of
cardiac morphogenesis. A threshold level of GATA4
between 30% and 50% of normal is required for normal
heart development and embryonic survival. Reduction of
GATA4 protein below this threshold resulted in reduced
cardiomyocyte replication, myocardial hypoplasia, and
endocardial cushion defects.Acknowledgments
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